CoChat

Sex-Based Differences in Outcomes After Mitral Valve Surgery for Severe Ischemic Mitral Regurgitation

Open access
Giustino, Gennaro, Overbey, Jessica, Taylor, Doris, Ailawadi, Gorav, Kirkwood, Katherine, DeRose, Joseph, Gillinov, Marc A., Dagenais, François, Mayer, Mary-Lou, Moskowitz, Alan, Bagiella, Emilia, Miller, Marissa, Grayburn, Paul, Smith, Peter K., Gelijns, Annetine, O'Gara, Patrick, Acker, Michael, Lala, Anuradha, Hung, Judy · 2019 · JACC: Heart Failure
Cited by 71

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Abstract

Objectives: To investigate sex-based differences in outcomes after mitral valve (MV) surgery for severe ischemic mitral regurgitation (SMR). Background: Whether differences in outcomes exist between men and women after surgery for SMR remains unknown. Methods: Patients enrolled in a randomized trial comparing MV replacement versus MV repair for SMR were included and followed for 2 years. Endpoints for this analysis included all-cause mortality, major adverse cardiovascular and cerebrovascular events (MACCE; defined as the composite of death, stroke, hospitalization for heart failure, worsening NYHA class or MV re-operation), quality of life. (QOL), functional status, and percentage change in left ventricular (LV) end-systolic volume index (LVESVI) from baseline through 2 years Results: Of 251 patients enrolled in the trial, 96 (38.2%) were women. Compared with men, women had smaller LV volumes and effective regurgitant orifice area (EROA) but greater EROA / LV end-diastolic volume ratio. At 2 years, women had higher rates of all-cause mortality (27.1% vs. 17.4%; adjusted hazard ratio [adjHR]: 1.85; 95% confidence interval [CI]: 1.05–3.26; p=0.03) and MACCE (49.0% vs. 38.1%; adjHR: 1.58; 95% CI: 1.06–2.37; p=0.02). Women also reported worse QOL and functional status at 2 years. There were no significant differences in the percentage change over 2 years in LVESVI between women and men (adjβ: −10.4; 95% CI: −23.4 to 2.6; p=0.12). Conclusions: Women with SMR display different echocardiographic features and experienced higher mortality and worse QOL after MV surgery compared with men. There were no significant differences in the degree of reverse LV remodeling between sexes. Clinical Trials.gov:

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.jchf.2019.03.001

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

  • Transcatheter Mitral-Valve Repair in Patients with Heart Failure

    Stone, G. W., Lindenfeld, J., Abraham, W. T., Kar, S., Lim, D. S., Mishell, J. M., Whisenant, B., Grayburn, P. A., Rinaldi, M., Kapadia, S. R., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1806640 · Cited by 3,017 · cited 1×

    “Similarly, in the recently completed COAPT (Cardiovascular Outcomes Assessment of the MitraClip Percutaneous Therapy for Heart Failure Patients With Functional Mitral Regurgitation) trial, correction of secondary severe MR with transcatheter MVRep compared with no correction reduced the risk of death or HF-rehospitali…”
    ResultSelf-citation

Cited by

See all 71

Metadata

Authors
Giustino, G., Overbey, J., Taylor, D., Ailawadi, G., Kirkwood, K., DeRose, J., Gillinov, M. A., Dagenais, F., Mayer, M.-L., Moskowitz, A., Bagiella, E., Miller, M., Grayburn, P., Smith, P. K., Gelijns, A., O'Gara, P., Acker, M., Lala, A., & Hung, J.
Venue
JACC: Heart Failure
Publisher
Elsevier BV
Published
2019-06
Volume
7
Issue
6
Pages
481-490
ISSN
2213-1779 (ISSN-L)
OpenAlex
W2918536328
Cited by
71
References
1
FWCI
5.38
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.